KRISTEN MORTON: Open Payments
NPI 1154610624 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 16 payments from 9 companies in 2025. Trend: 2023 $161 · 2024 $231 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $143 |
| Lilly USA, LLC | 3 | $66 |
| ABBVIE INC. | 3 | $56 |
| Astellas Pharma US Inc | 2 | $48 |
| Organon LLC | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: Wegovy, MOUNJARO, Veozah, NEXPLANON, QULIPTA, Symbravo, FREESTYLE LIBRE 3, SHINGRIX.
Industry payments across TX — which companies pay providers there.
